FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2060943721> ?p ?o ?g. }

• W2060943721 endingPage "240" @default.
• W2060943721 startingPage "236" @default.
• W2060943721 abstract "The recovery of immunoregulatory cells in the peripheral blood of patients with multiple myeloma receiving maintenance therapy with interferon alpha 2 beta (IFN-alpha 2 beta) after intensive therapy with high-dose melphalan and autologous bone marrow or peripheral blood stem cell rescue was studied. IFN-alpha 2 beta significantly inhibited the recovery of CD3+, CD4+, CD8+, CD56+/CD3- and CD16+/CD3- lymphocytes compared with numbers found in patients who had no further post-transplant treatment, but had no effect on the recovery of CD19+ cells. Among patients who did not receive IFN-alpha 2 beta, the number of CD8+, CD56+/CD3- and CD16+CD3- lymphocytes recovered to values similar to normal volunteers with increasing time after intensive therapy, however the number of CD4+ cells remained significantly below levels found in normal volunteers. Although CD16+/CD3- and CD56+/CD3- cell numbers were reduced in patients receiving IFN-alpha 2 beta, natural killer (NK) activity was not affected. The levels of soluble interleukin 2 receptor (sIL-2R) were similar in all patients and IL-2 was not detected in any patient. At the time of writing, of the total of 69 patients, seven have relapsed, of whom three were receiving IFN-alpha 2 beta, however there was no correlation between the absolute numbers of any lymphocyte subset with imminent relapse. The data suggest that the recovery of a specific lymphocyte subset(s) in peripheral blood is unlikely to be associated with the maintenance of response after intensive therapy." @default.
• W2060943721 created "2016-06-24" @default.
• W2060943721 creator A5014303737 @default.
• W2060943721 creator A5053915128 @default.
• W2060943721 creator A5065660823 @default.
• W2060943721 date "1996-01-01" @default.
• W2060943721 modified "2023-10-06" @default.
• W2060943721 title "Lymphocyte recovery and clinical response in multiple myeloma patients receiving interferon alpha 2 beta after intensive therapy" @default.
• W2060943721 cites W147513325 @default.
• W2060943721 cites W1497205974 @default.
• W2060943721 cites W1509043987 @default.
• W2060943721 cites W1536898507 @default.
• W2060943721 cites W1571629216 @default.
• W2060943721 cites W184351544 @default.
• W2060943721 cites W1963647417 @default.
• W2060943721 cites W1964857102 @default.
• W2060943721 cites W1998848273 @default.
• W2060943721 cites W2003212494 @default.
• W2060943721 cites W2021917806 @default.
• W2060943721 cites W2023674080 @default.
• W2060943721 cites W2051694232 @default.
• W2060943721 cites W2071965962 @default.
• W2060943721 cites W2080475374 @default.
• W2060943721 cites W2105844501 @default.
• W2060943721 cites W2119013267 @default.
• W2060943721 cites W2142188119 @default.
• W2060943721 cites W2288060887 @default.
• W2060943721 cites W2408849246 @default.
• W2060943721 cites W2411495263 @default.
• W2060943721 cites W2418058986 @default.
• W2060943721 cites W3134708772 @default.
• W2060943721 doi "https://doi.org/10.1038/bjc.1996.41" @default.
• W2060943721 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2074310" @default.
• W2060943721 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8546912" @default.
• W2060943721 hasPublicationYear "1996" @default.
• W2060943721 type Work @default.
• W2060943721 sameAs 2060943721 @default.
• W2060943721 citedByCount "2" @default.
• W2060943721 countsByYear W20609437212012 @default.
• W2060943721 crossrefType "journal-article" @default.
• W2060943721 hasAuthorship W2060943721A5014303737 @default.
• W2060943721 hasAuthorship W2060943721A5053915128 @default.
• W2060943721 hasAuthorship W2060943721A5065660823 @default.
• W2060943721 hasBestOaLocation W20609437211 @default.
• W2060943721 hasConcept C114684123 @default.
• W2060943721 hasConcept C126322002 @default.
• W2060943721 hasConcept C141071460 @default.
• W2060943721 hasConcept C154317977 @default.
• W2060943721 hasConcept C167672396 @default.
• W2060943721 hasConcept C202751555 @default.
• W2060943721 hasConcept C203014093 @default.
• W2060943721 hasConcept C2775944032 @default.
• W2060943721 hasConcept C2776178377 @default.
• W2060943721 hasConcept C2776364478 @default.
• W2060943721 hasConcept C2777761686 @default.
• W2060943721 hasConcept C2778102761 @default.
• W2060943721 hasConcept C2778684742 @default.
• W2060943721 hasConcept C2778957590 @default.
• W2060943721 hasConcept C2780218660 @default.
• W2060943721 hasConcept C2781228144 @default.
• W2060943721 hasConcept C2909179924 @default.
• W2060943721 hasConcept C49453240 @default.
• W2060943721 hasConcept C55493867 @default.
• W2060943721 hasConcept C64943373 @default.
• W2060943721 hasConcept C71924100 @default.
• W2060943721 hasConcept C86803240 @default.
• W2060943721 hasConcept C8891405 @default.
• W2060943721 hasConcept C90924648 @default.
• W2060943721 hasConceptScore W2060943721C114684123 @default.
• W2060943721 hasConceptScore W2060943721C126322002 @default.
• W2060943721 hasConceptScore W2060943721C141071460 @default.
• W2060943721 hasConceptScore W2060943721C154317977 @default.
• W2060943721 hasConceptScore W2060943721C167672396 @default.
• W2060943721 hasConceptScore W2060943721C202751555 @default.
• W2060943721 hasConceptScore W2060943721C203014093 @default.
• W2060943721 hasConceptScore W2060943721C2775944032 @default.
• W2060943721 hasConceptScore W2060943721C2776178377 @default.
• W2060943721 hasConceptScore W2060943721C2776364478 @default.
• W2060943721 hasConceptScore W2060943721C2777761686 @default.
• W2060943721 hasConceptScore W2060943721C2778102761 @default.
• W2060943721 hasConceptScore W2060943721C2778684742 @default.
• W2060943721 hasConceptScore W2060943721C2778957590 @default.
• W2060943721 hasConceptScore W2060943721C2780218660 @default.
• W2060943721 hasConceptScore W2060943721C2781228144 @default.
• W2060943721 hasConceptScore W2060943721C2909179924 @default.
• W2060943721 hasConceptScore W2060943721C49453240 @default.
• W2060943721 hasConceptScore W2060943721C55493867 @default.
• W2060943721 hasConceptScore W2060943721C64943373 @default.
• W2060943721 hasConceptScore W2060943721C71924100 @default.
• W2060943721 hasConceptScore W2060943721C86803240 @default.
• W2060943721 hasConceptScore W2060943721C8891405 @default.
• W2060943721 hasConceptScore W2060943721C90924648 @default.
• W2060943721 hasIssue "2" @default.
• W2060943721 hasLocation W20609437211 @default.
• W2060943721 hasLocation W20609437212 @default.
• W2060943721 hasLocation W20609437213 @default.
• W2060943721 hasLocation W20609437214 @default.
• W2060943721 hasOpenAccess W2060943721 @default.

• next